Michael Jackson, PhD

Research summary

Dr. Michael Jackson's research focuses on understanding the role of Ca2+-permeable channels in Ca2+ dysregulation, inflammation, and impaired synaptic transmission and plasticity in models of stroke and Alzheimer's disease. His work has shown that channels such as TRPM2 and pannexin are functionally linked to the NMDA glutamate receptor, and that these channels play a role in both physiological and pathological processes. The primary goal of his research is to gain insight into how these channels are regulated by intracellular signaling pathways, with the ultimate aim of identifying molecular targets for the development of effective treatments for neurodegenerative disorders. Dr. Jackson is a principal investigator in the neuroscience research program at the Kleysen Institute for Advanced Medicine, Health Sciences Centre.

Research affiliations

Principal investigator, neuroscience research program, Kleysen Institute for Advanced Medicine, Health Sciences Centre

Biography

Dr. Michael Jackson is an accomplished scientist and academic who is currently a professor in pharmacology and therapeutics at the University of Manitoba. He is the principal investigator of the neuroscience research program at the Kleysen Institute for Advanced Medicine (KIAM) and his laboratory is located in the neurosciences research laboratories in KIAM.

Dr. Jackson received his PhD in pharmacology and therapeutics from McGill University in 1998. Following his graduation, he completed postdoctoral training in physiology at the University of Toronto. He then moved to the Robarts Research Institute at Western University in 2008, where he worked as a research scientist and adjunct professor of psychiatry and pharmacology. Throughout his career, Dr. Jackson has made significant contributions to the field of neuroscience, with a specific focus on understanding the role of Ca2+-permeable channels in Ca2+ dysregulation, inflammation, and impaired synaptic transmission and plasticity in models of stroke and Alzheimer's disease. He has published several research papers in reputable journals and has gained an international reputation as an expert in his field.

Education

  • PhD (pharmacology and therapeutics), McGill University (1998)

  • Postdoctoral fellow (physiology), University of Toronto (2008)

Contact us

Pharmacology and Therapeutics
Max Rady College of Medicine
A205 Chown Bldg., 753 McDermot Avenue
University of Manitoba (Bannatyne campus)
Winnipeg, MB R3E 0T6 Canada

pharmacology@umanitoba.ca
204-789-3553